Impact of photoselective vaporization of the prostate (PVP-XPS) on work productivity in working-age men with benign prostatic hyperplasia requiring surgical treatment

Impact of photoselective vaporization of the prostate (PVP-XPS) on work productivity in working-age men with benign prostatic hyperplasia requiring surgical treatment - Impact of photoselective vaporization of the prostate (PVP-XPS) on work productivity

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060902

Enrollment

Registered

2026-03-12

Start date

2026-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Patients with benign prostatic hyperplasia undergoing photoselective vaporization of the prostate. 2.Male patients aged 40 years or more. 3.Patients with an estimated prostate volume of 30 to 80 g. 4.Patients who provide written informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: 1.Patients who are unable to speak Japanese. 2.Patients with anatomical abnormalities of the urinary tract. 3.Patients with a history of surgical intervention for benign prostatic hyperplasia. 4.Patients deemed unsuitable for the study by the attending physician.

Design outcomes

Primary

Measure	Time frame
Change from baseline in overall work impairment (%) assessed by the Work Productivity and Activity Impairment (WPAI) questionnaire at 1, 3, and 6 months after PVP	—

Secondary

Measure	Time frame
Change from baseline in absenteeism, presenteeism, overall activity impairment, and productivity loss cost assessed by the Work Productivity and Activity Impairment (WPAI) questionnaire at 1, 3, and 6 months after PVP Change from baseline in the International Prostate Symptom Score (IPSS), Overactive Bladder Symptom Score (OABSS) and the simple frailty index at 1, 3, and 6 months after PVP	—

Countries

Japan

Contacts

Public ContactAtsushi Wanifuchi

Japanese Red Cross Kushiro Hospital Department of Urology

a-wanifuchi@sapmed.ac.jp+81-154-22-7171

Outcome results